Dr. Jeffrey S. Borer is an exceptional RESEARCHER and CLINICIAN on a lifelong mission to create new knowledge that advances the practice of cardiovascular medicine

Current Appointments and Positions
  • Dr. Borer is Professor of Medicine, Cell Biology, Radiology, Surgery and Public Health at the State University of New York Downstate College of Medicine and School of Public Health.
  • He is also Adjunct Professor of Cardiovascular Medicine in Cardiothoracic Surgery at Weill Medical College of Cornell University.
  • For many years he also served as Chief, Division of Cardiovascular Medicine and, simultaneously, as Chairman, Department of Medicine, at SUNY Downstate.
  • At Cornell and at Downstate, he performs clinical service, teaching, and research, the latter primarily developing prognosticators for regurgitant valve diseases (leaking heart valves), and assessing the effects of drugs, devices, and heart rate slowing on clinical outcomes, with trials on coronary artery disease and heart failure.
Exceptional Preparation for an Exceptional Career
  • Dr. Borer received a BA from Harvard 
  • MD from Cornell,
  • trained at the Massachusetts General Hospital,
  • spent 7 years in the Cardiology Branch of the National Heart Lung and Blood Institute at the National Institutes of Health (NHLBI),
  • and a year at Guy’s Hospital (London) as a Senior Fullbright Hays Scholar and a Glorney-Raisbeck Fellow in the Medical Sciences,
  • where he completed the first clinical demonstration of nitroglycerin’s utility in acute MI (heart attack).
  • Upon returning to NIH, he developed stress radionuclide cineangiography, enabling the first non-invasive assessment of cardiac function with exercise and importantly changing the practice of cardiology.

Dr. Borer then returned to Cornell for 30 years as Gladys and Roland Harriman Professor of Cardiovascular Medicine and Chief, Division of Cardiovascular Pathophysiology.

Currently Directing Two Research Institutes at Downstate
  • The Howard Gilman Institute for Heart Valve Disease
  • Schiavone Institute of Cardiovascular Translational Research.

Dr. Borer has designed, led, and participated in numerous clinical trials and his groundbreaking research has been supported by:

  • National Institutes of Health (NIH)
  • American Heart Association (AHA)
  • several private foundations.
Numerous Recognitions for Clincial, Research, and Advisory Service
  • FDA Service Award.
  • Public Service Medal of NASA.
  • Lifetime Achievement Award of the Heart Valve Society of America and Society of Heart Valve Disease of Europe (2014).
  • Legends of Cardiology award at the 10th Annual Complex Catheter-based Cardiovascular Therapeutics conference (2014).
  • Albert Nelson Marquis Lifetime Achievement Award (2017 from Who’s Who).
  • Distinguished Humanitarian Award (2018 from Who’s Who).
  • Top Professor of the Year in Medicine for 2018 by the International Association of Top Professionals (IAOTP), for his outstanding leadership, dedication, and commitment to the health field.
  • Kanu Chatterjee Lifetime Achievement Award for outstanding contributions to the field of Cardiovascular Medicine — presented at the 23rd World Congress on Heart Disease at the International Academy of Cardiology, Annual Scientific Sessions 2018.
Distinguished Advisor to National and International Regulatory Bodies
  • Advisor to the USFDA for more than 40 years (ongoing).
  • chaired the CardioRenal Drugs Advisory Committee for 3 terms.
  • chaired the Circulatory Devices Advisory Panel for one term.
  • life sciences Advisor to NASA for 24 years.
  • currently Chairman of the Cardiovascular Devices Committee of the International Standardization Organization (ISO) — which sets the manufacturing and approval standards for all mechanical cardiovascular devices outside the U.S. (such as substitute heart valves) — and a member of the ISO’s Valve Diseases Working Group (TC-150 SC2).
Editor and Author at the Highest Levels of Medical and Scientific Scholarship
  • editor-in-chief, Cardiology 2005 – 2018
  • editorial board member of 14 additional peer-reviewed cardiovascular journals:
    • Nuclear Cardiology Section, Journal of Clinical Pharmacology, 1991-1994
    • Nuclear Medicine Section, and editorial board, American Journal of Therapeutics, 1993-2015 (ceased publication)
    • Valve Disease, Journal of the American College of Cardiology, 2014 – present
    • Dialogues in Cardiovascular Medicine, 2016 – present
    • American Journal of Cardiac Imaging, 1986 – present
    • Journal of Nuclear Cardiology, 1993 – 1997
    • The Journal of Heart Failure, 1994 – present
    • Journal of Preventive Cardiology, 1996 – 2010 (journal ceased publication in 2010)
    • Journal of Clinical and Basic Cardiology, 1998 – present
    • Journal of Heart Disease, 1999 – present
    • European Heart Journal, 2008 – present
    • Journal of Geriatric Cardiology, 2013 – present
    • Cardiology and Therapy (Springer), 2014 – present
    • Clinical Research in Cardiology, 2014 – present
  • published more than 500 full-length scientific papers and book chapters
  • authored or edited 8 books, including Contemporary Diagnosis (monograph by Borer) and Management of Valvular Heart Diseases and Principles of Research Methodology: A Guide for Clinical Investigators (co-edited with his longtime colleague, Dr. Phyllis Supino).
Leadership Service on many of Cardiovascular Medicine’s most Prestigious Societies
  • Board of Directors, Heart Valve Society, international, 2015 – present
  • Founding President, Heart Valve Society of America 2004-2014.
  • Board of Governors, The Society for Cardiac Angiography and Interventions, 1995-2000
  • Board of Governors, American College of Cardiology, 1998 – 2000
  • Board of Trustees, Certification Board of Nuclear Cardiology, 1996 – 2000
  • Board of Directors, Cardiovascular Council, Society of Nuclear Medicine, 1991 – 1995